CAREFOR: safeguarding the future of independent academic research in Europe for the benefit of cancer patients

CAREFOR: the Clinical Academic Cancer Research Forum, was created, in 2014, as a collaborative initiative by European Society of Medical Oncology (ESMO) and the European Organisation for Research and Treatment of Cancer (EORTC), and later joined by the European Association for Cancer Research (EACR) to address current issues related to clinical academic cancer research.

Academic clinical research, or non-commercial research, is crucial for advancing cancer care. Academia-based researchers have driven many therapeutic breakthroughs and standards of treatments by validating complex therapeutic strategies from which countless patients across the globe have benefited from practice-changing discoveries. In addition, independent clinical cancer research plays a crucial role in personalised medicine and refining the use of available treatments. It is also critical for advances in rare cancers because the small patient population makes it unattractive for commercial entities to pursue research in this field.

CAREFOR brings together leading experts from Europe with the goal to safeguard and improve the organisation, recognition, and funding of academic clinical research in oncology, and ensure that the EU legislative framework supports the development of academic clinical research.

To learn more please view: https://www.esmo.org/policy/carefor-the-clinical-academic-cancer-research-forum